The Oncology Institute Announces CFO Transition
TOI Stock | USD 0.96 0.16 20.00% |
Under 72 percent of all Oncology Institute's traders are curious in acquiring. The analysis of overall sentiment of trading Oncology Institute stock suggests that a large number of investors are confidant at this time. Oncology Institute's investing sentiment shows overall attitude of investors towards Oncology Institute.
Oncology |
Rob Carter promoted to Chief Financial OfficerCERRITOS, Calif., Sept. 23, 2024 -- The Oncology Institute, Inc. , today announced that Chief Financial Officer, Mihir Shah, will transition out of the organization effective October 14, 2024, to pursue other opportunities. Rob Carter, Senior Vice President of Finance at TOI, will be promoted to Chief Financial Officer. Mr. Carter brings over a decade of finance leadership experience across sever
Read at finance.yahoo.com
![]() |
Oncology Institute Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Oncology Institute can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Oncology Institute Fundamental Analysis
We analyze Oncology Institute's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncology Institute using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncology Institute based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Oncology Institute is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Oncology Institute Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncology Institute stock to make a market-neutral strategy. Peer analysis of Oncology Institute could also be used in its relative valuation, which is a method of valuing Oncology Institute by comparing valuation metrics with similar companies.
Peers
Oncology Institute Related Equities
ENSG | Ensign | 5.28 | ||||
FSNUY | Fresenius | 4.75 | ||||
CCM | Concord Medical | 3.93 | ||||
SEM | Select Medical | 3.45 | ||||
PNTG | Pennant | 2.47 | ||||
EHC | Encompass Health | 1.77 | ||||
SGRY | Surgery Partners | 1.11 | ||||
JYNT | Joint Corp | 0.44 | ||||
RMYHY | Ramsay Health | 0.18 | ||||
MFCSF | Medical Facilities | 0.08 | ||||
LFST | Lifestance Health | 0.13 | ||||
AMS | American Shared | 0.34 | ||||
BKD | Brookdale Senior | 1.19 | ||||
SNDA | Sonida Senior | 1.64 | ||||
ADUS | Addus HomeCare | 1.90 | ||||
MD | Mednax | 2.60 | ||||
UHS | Universal Health | 4.70 | ||||
AGL | Agilon Health | 7.44 |
Complementary Tools for Oncology Stock analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |